HIGH-RISK RECTAL CANCER NEO-ADJUVANT CAPECITABINE AND OXALIPLATIN BEFORE RADIOTHERAPY WITH CONCOMITANT CAPECITABINE AND RADICAL SURGERY LOCOREGIONAL RESPONSE

被引：0
|
作者：
Brodmann, S. [1 ]
Bateman, A. C.
Bateman, A. [1 ]
机构：
[1] Southampton Gen Hosp, Radiotherapy Ctr, Southampton, Hants, England
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2010年 / 186卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：724 / 725
页数：2
相关论文
共 50 条
  • [1] Capecitabine and Oxaliplatin Before, During, and After Radiotherapy for High-Risk Rectal Cancer
    Larsen, Finn Ole
    Markussen, Alice
    Jensen, Benny V.
    Fromm, Anne L.
    Vistisen, Kirsten K.
    Parner, Vibeke K.
    Linnemann, Dorte
    Hansen, Rasmus H.
    Johannesen, Helle H.
    Schou, Jakob V.
    CLINICAL COLORECTAL CANCER, 2017, 16 (02) : E7 - E14
  • [2] Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study
    Carlomagno, C.
    Farella, A.
    Bucci, L.
    D'Armiento, F. P.
    Pesce, G.
    Pepe, S.
    Cannella, L.
    Pacelli, R.
    De Stefano, A.
    Solla, R.
    D'Armiento, M. R.
    De Placido, S.
    ANNALS OF ONCOLOGY, 2009, 20 (05) : 906 - 912
  • [3] NEO-ADJUVANT THERAPY WITH ORAL CAPECITABINE (CAPE) plus OXALIPLATIN (OXA) AND CONCURRENT RADIOTHERAPY (RT) IN RECTAL CANCER
    Dottori, R.
    Mazzocchi, B.
    Andrei, A.
    Bonifazi, V. F.
    Schiaroli, G.
    Pecci, A. P.
    Perillo, F.
    Algeri, R.
    Tucci, E.
    ANNALS OF ONCOLOGY, 2004, 15 : 61 - 61
  • [4] Oxaliplatin and capecitabine initially concomitant to radiotherapy then administered in the resting period in high-risk locally advanced rectal cancer
    Ding, Pei-Rong
    Gao, Yuan-Hong
    An, Xin
    Chen, Gong
    Wang, Feng-Hua
    Cai, Mu-Yan
    Zeng, Zhi-Fan
    Kong, Ling-Heng
    Lin, Jun-Zhong
    Wu, Xiaojun
    Lu, Zhen-Hai
    Li, Li-Ren
    Wan, De-Sen
    Pan, Zhi-Zhong
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [5] Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer
    Gao, Yuan-Hong
    An, Xin
    Sun, Wei-Jiang
    Cai, Juan
    Cai, Mu-Yan
    Kong, Ling-Heng
    Lin, Jun-Zhong
    Liu, Guo-Chen
    Tang, Jing-Hua
    Wu, Xiao-Jun
    Chen, Gong
    Pan, Zhi-Zhong
    Ding, Pei-Rong
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (05) : 478 - 482
  • [6] Oxaliplatin and capecitabine concomitant with neoadjuvant radiotherapy and extended to the resting period in high risk locally advanced rectal cancer
    Gao, Y. -H.
    Zhang, X.
    An, X.
    Cai, M. -Y.
    Zeng, Z. -F.
    Chen, G.
    Kong, L. -H.
    Lin, J. -Z.
    Wan, D. -S.
    Pan, Z. -Z.
    Ding, P. -D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (02) : 158 - 164
  • [7] Capecitabine and oxaliplatin as induction and concomitant with radiotherapy in rectal cancer: A phase II study
    Gutierrez, J. A.
    Martinez-Martinez, G.
    Silva, A. J.
    Gomez Rangel, J., Sr.
    Palmerin, M.
    Gutierrez, M.
    Garcia, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [8] Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer
    Hasegawa, Junichi
    Nishimura, Junichi
    Mizushima, Tsunekazu
    Miyake, Yasuhiro
    Kim, Ho Min
    Takemoto, Hiroyoshi
    Tamagawa, Hroshi
    Noura, Shingo
    Fujii, Makoto
    Fujie, Yujiro
    Kato, Takeshi
    Miwa, Hideaki
    Takemasa, Ichiro
    Ikeda, Masataka
    Yamamoto, Hirofumi
    Sekimoto, Mistugu
    Nezu, Riichiro
    Doki, Yuichiro
    Mori, Masaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (05) : 1079 - 1087
  • [9] Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer
    Junichi Hasegawa
    Junichi Nishimura
    Tsunekazu Mizushima
    Yasuhiro Miyake
    Ho Min Kim
    Hiroyoshi Takemoto
    Hroshi Tamagawa
    Shingo Noura
    Makoto Fujii
    Yujiro Fujie
    Takeshi Kato
    Hideaki Miwa
    Ichiro Takemasa
    Masataka Ikeda
    Hirofumi Yamamoto
    Mistugu Sekimoto
    Riichiro Nezu
    Yuichiro Doki
    Masaki Mori
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 1079 - 1087
  • [10] AXE BEAM: ENCOURAGING EARLY RESULTS OF A NEO-ADJUVANT BEVACIZUMAB, CAPECITABINE +/- OXALIPLATIN AND RADIATION MULTIMODALITY REGIMEN FOR LOCALLY ADVANCED RECTAL CANCER
    Chiritescu, G.
    Dumon, K.
    Vergauwe, P.
    Arts, J.
    D'Hoore, A.
    Debucquoy, A.
    Verstraete, M.
    Sagaert, X.
    Haustermans, K.
    Van Cutsem, E.
    ANNALS OF ONCOLOGY, 2012, 23 : 222 - 222
12345